CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma. - Wikidata - awgldk - TriplyDB

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

http://www.wikidata.org/entity/Q35095013

about

Inhibition of multiple protective signaling pathways and Ad.5/3 delivery enhances mda-7/IL-24 therapy of malignant glioma Is there a common upstream link for autophagic and apoptotic cell death in human high-grade gliomas?Current status of gene therapy for brain tumors.Oncolytic adenoviruses: A thorny path to glioma cure Gene therapy for cancer: present status and future perspective Neural transmembrane protease and endothelial Gs protein activation in cell contact-dependent signaling between neural stem/progenitor cells and brain endothelial cells.Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo."Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.Combining conditionally replicating adenovirus-mediated gene therapy with chemotherapy: a novel antitumor approach.Conditionally replicating adenoviruses carrying mda-7/IL-24 for cancer therapy.Optimization and preclinical design of genetically engineered viruses for human oncolytic therapy.Recent advances in delivery of drug-nucleic acid combinations for cancer treatment Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities.Progression of O⁶-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research.Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma.Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment.Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro.

P2860

Q33930115-6642B787-7128-48E9-A607-E4A59628FEE5 Q34197351-C0BAC5DB-8492-49D9-ACCF-8378137B33E9 Q34318157-E1CA266C-8EEF-4D58-B350-680082235DCF Q35077747-A0E8801A-8DC9-4B0A-B987-5379D6E5535E Q35673900-A0DB4533-B9BE-4A4C-BD2A-E4C173656D92 Q36080378-B4D6E76F-8FBD-4AE0-8B0D-AC8FC4281778 Q36372763-995CF7D4-4DA2-49D8-BD17-0CB634EF8982 Q37622288-5602CCC4-7593-49DD-9ACC-E410715906EF Q37867584-78278A49-B67F-455E-837A-BC4417DF0DD4 Q37945288-37EC9BA1-AA41-46E2-9812-D3342D8EF2EA Q38025696-30AC3AD0-9B68-427D-8915-7F5F43274AC0 Q38102522-135FE0EC-77BD-43BE-BAD9-2E8DF88511EC Q38174692-500E8EAE-6F65-4D53-A9C2-38BEF6E5DEE0 Q38225830-3D6B230F-EBBC-4C4B-AB8E-D7CDFFF65BFD Q39215780-5DFE00E5-F5CE-49A3-B789-99F011CBA48C Q42279694-27BBD77A-9313-4E6A-981C-7548EE6463BE Q50052813-9C979B2B-A059-49E4-B5E0-276AE52FF0DF Q54207869-3F77E38E-737C-423D-A750-F3D2E5CF3310

P2860

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

http://www.wikidata.org/entity/Q35095013

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

@ast

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

@en

type

label

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

@ast

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

@en

prefLabel

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

@ast

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

@en

P1433

Q35095013-4B61BA9F-1B8F-475B-81FE-AEC114DB424C

P1476

Q35095013-3DBE16E4-7E8D-47CF-ABD0-8854B4DF1252

P2093

Q35095013-0025A3E0-E9C4-4650-A683-948B967167ED

Q35095013-02FF3B50-396D-4653-8B28-D53CB36C6C2D

Q35095013-13FF065C-52A4-4778-9230-4A9A966B675D

Q35095013-33CA77BA-E092-45C6-B929-3D1F10FA6281

Q35095013-39939903-3798-4EBE-8722-538E00506066

Q35095013-9E0B58C3-D6A6-405C-B8C2-631932D1479E

Q35095013-D2D4AB8B-277E-466A-A213-6786FF909FC4

Q35095013-DA666043-94AA-492B-9BBE-AD87B451ED32

Q35095013-FE5942FB-167A-49D5-8BD2-C835337274ED

P2860

Q35095013-0471E07F-D342-4F4D-8FA9-5231F465C0DB

Q35095013-04E1E14E-3B3C-4B8B-8CF2-1BD346DFF3B6

Q35095013-0679AFB2-2CE6-4D66-A133-BFE66E856035

Q35095013-069E4731-151F-4CC2-92C7-1C323A2ACF41

Q35095013-0AE77486-E0E1-4D5D-A2D1-30A5DCC38B5A

Q35095013-0F1AF4CD-07D8-40C3-B2B0-BA45398F1C65

Q35095013-143ACE40-993E-44AC-869F-EB50A2136332

Q35095013-17FFC5A3-AF25-4CA5-960C-572678E3BA1E

Q35095013-258BAECC-38B3-44F1-99C2-86DB4726A89C

Q35095013-2E2711E6-F91D-4BE3-B56C-EC159CD59C92

P2888

Q35095013-79FADFF3-1431-4150-9812-BA5A0B8130BD

P304

Q35095013-EBF998E3-9175-46E3-ABA1-27EB8951633F

P31

Q35095013-CE426B71-CCE8-49A8-A617-3F2E00B4974B

P356

Q35095013-6EC6285C-157D-4D1D-81BF-467C4557D7F8

P433

Q35095013-6B9D757B-5E55-493B-A70E-97B0DC2E4D2B

P478

Q35095013-546CA529-36BF-4940-BEC2-24CE00AE20A4

P50

Q35095013-40D36AA6-C236-4C35-83EF-808F2535658B

P577

Q35095013-FB2E294F-9D15-4ECA-9FC5-FED2E41E2517

P5875

Q35095013-9988CBAA-3063-4748-8035-06C5310D7F53

P698

Q35095013-38498AA1-AA83-4B51-90D2-C64EA8ECA65D

P921

Q35095013-E2E19C92-0C96-4B87-89AD-C8C562FEFC10

P932

Q35095013-60B09896-4882-4833-85EF-B5CB404A2A4A

P356

P1433

Cancer Gene Therapy

P1476

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma

@en

P2093

A S Petersen

http://www.w3.org/2001/XMLSchema#string

C R Stockard

http://www.w3.org/2001/XMLSchema#string

D K Harmon

http://www.w3.org/2001/XMLSchema#string

G Y Gillespie

http://www.w3.org/2001/XMLSchema#string

J M Markert

http://www.w3.org/2001/XMLSchema#string

L N Kaliberova

http://www.w3.org/2001/XMLSchema#string

S A Kaliberov

http://www.w3.org/2001/XMLSchema#string

V Krendelchtchikova

http://www.w3.org/2001/XMLSchema#string

W E Grizzle

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

Self-eating and self-killing: crosstalk between autophagy and apoptosis

Angiogenesis in brain tumors.

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials.

Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide.

Apoptosis: a link between cancer genetics and chemotherapy.

P2888

P304

794-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CGT.2009.23

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Donald J Buchsbaum

P577

2009-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24274786

http://www.w3.org/2001/XMLSchema#string

P698

19363468

http://www.w3.org/2001/XMLSchema#string

P921

P932

4332514

http://www.w3.org/2001/XMLSchema#string